Opportunities for improving the efficiency of paediatric HIV treatment programmes. - Wikidata - awgldk - TriplyDB

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

http://www.wikidata.org/entity/Q35054163

about

The Need for Pediatric Formulations to Treat Children with HIV Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire

P2860

Q26740369-343B410A-DB31-45AA-9D0B-4E71745D9C80 Q28554853-8E0FE1D1-0963-4A8C-9308-0FB849B1845E

P2860

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

http://www.wikidata.org/entity/Q35054163

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@ast

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@en

type

label

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@ast

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@en

prefLabel

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@ast

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@en

P1433

Q35054163-446322AD-B3E7-4802-B4C2-DBE34C78DBE0

P1476

Q35054163-743EA55F-A25D-4F6C-A929-9FF3AC7BE842

P2093

Q35054163-38CF9132-65BD-457C-8A07-6D22D633474B

Q35054163-4E01A2CB-76B3-495C-A5CB-DD4787E5C3BF

Q35054163-4E724A63-A885-4C23-9985-65C438A26A18

Q35054163-4FEF9267-4565-411C-8D3F-DDCB29126542

Q35054163-50BBB095-8440-4315-8927-AA4BBC186B2B

Q35054163-93769136-3839-4541-9284-C22E32B54035

Q35054163-B9D1E890-4EE6-4EFC-BA02-EFE1897DFD8B

Q35054163-BEC84960-E213-4BBB-8645-541D0BB8E558

Q35054163-D3CE3654-CB97-494E-ACFA-EFD05F65F32C

Q35054163-D9549498-8BE9-41C5-BACD-CA87BE9073F8

P2860

Q35054163-1979D4E2-D454-4B62-962A-A7CBF8E38661

Q35054163-20EC3AB1-53FD-4AC1-8344-FBB2DB615757

Q35054163-219EB843-2645-48D5-8FCF-F76F2A3C970C

Q35054163-24341441-D1AF-4519-B680-83708CD46100

Q35054163-3074D27B-57F9-443D-A2D6-9E0583B1B991

Q35054163-89970A7D-6719-478E-B5E2-7E6BAA0F3952

Q35054163-98E68E9C-4EB0-4BCD-AFFA-63D3EB10C2D8

Q35054163-A8AE01CA-1D46-4003-93FA-8DEC3B7ED63B

Q35054163-AA62E522-431C-47DB-95DC-E0D0224712E8

Q35054163-BF317A9C-FC68-4D6F-8A2B-6FD4FA1D7C4B

P304

Q35054163-78668133-18EA-427E-B0B2-F01DF11EEF2C

P31

Q35054163-0697FE1B-360C-493C-B98C-45EB334E592C

P356

Q35054163-84CB248C-BC18-4B25-A3E7-32CB36F4986F

P407

Q35054163-68490C4C-D800-4547-9A65-852893D48368

P433

Q35054163-8B359FBA-15A9-4FDF-B158-6AB7B849ADCB

P478

Q35054163-07DA3769-4021-466D-AE66-DA21EC067262

P50

Q35054163-8F5C6A27-BBBA-4A73-BDAC-2C4B74488384

Q35054163-C030C02A-3115-4C85-8A8A-93A266260CF3

Q35054163-E0325E93-BEFF-41DD-97DC-2E7B8E7C1913

P577

Q35054163-FA507D21-0680-4B7A-B586-8259F46365CD

P698

Q35054163-865C7F39-BB6C-44E1-8E28-7C1E18874DE3

P932

Q35054163-F715D991-D519-4BF5-BC4B-4CB10814EF40

P356

QAD.0000000000000518

P1433

P1476

Opportunities for improving the efficiency of paediatric HIV treatment programmes.

@en

P2093

A Sarah Walker

http://www.w3.org/2001/XMLSchema#string

Adeodata Kekitinwa

http://www.w3.org/2001/XMLSchema#string

Diana M Gibb

http://www.w3.org/2001/XMLSchema#string

Kusum J Nathoo

http://www.w3.org/2001/XMLSchema#string

Mark J Sculpher

http://www.w3.org/2001/XMLSchema#string

Patricia Nahirya-Ntege

http://www.w3.org/2001/XMLSchema#string

Paul A Revill

http://www.w3.org/2001/XMLSchema#string

Paula Munderi

http://www.w3.org/2001/XMLSchema#string

Peter Mugyenyi

http://www.w3.org/2001/XMLSchema#string

Simon Walker

http://www.w3.org/2001/XMLSchema#string

P2860

Paying for performance to improve the delivery of health interventions in low- and middle-income countries

Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factorial trial.

Cost-effectiveness acceptability curves--facts, fallacies and frequently asked questions.

Constraints to implementing the Essential Health Package in Malawi.

The Lablite project: a cross-sectional mapping survey of decentralized HIV service provision in Malawi, Uganda and Zimbabwe

A randomized trial of prolonged co-trimoxazole in HIV-infected children in Africa

Scaling up antiretroviral therapy in Uganda: using supply chain management to appraise health systems strengthening.

Alternative antiretroviral monitoring strategies for HIV-infected patients in east Africa: opportunities to save more lives?

Cost-effectiveness of different strategies to monitor adults on antiretroviral treatment: a combined analysis of three mathematical models.

P304

201-210

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAD.0000000000000518

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

29

http://www.w3.org/2001/XMLSchema#string

P50

Sabrina Bakeera-Kitaka

Mutsawashe Bwakura-Dangarembizi

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25396263

http://www.w3.org/2001/XMLSchema#string

P932

4318642

http://www.w3.org/2001/XMLSchema#string